Ovarian cancer is the most common cause of gynecological cancer death lacking early diagnosis biomarkers and initial symptoms, so it is entitled of “silent woman killer” [1]. Because epithelial ovarian cancer (EOC) has the highest incidence, many scholars have conducted in-depth research...
Breast cancer remains the most common malignancy and the leading cause of cancer deaths in women worldwide [1]. Breast cancer accounts for about one fourth of cancer cases and about one sixth of cancer deaths in women globally [1]. In clinical practice, breast cancer is considered to consist of four...
Ovarian cancer (OC) remains a formidable challenge in the realm of gynecologic malignancies due to its high lethality. It is characterized by a lack of reliable early diagnostic methods and specific warning signs, resulting in most OC cases being diagnosed at advanced stages with a grim prognosis [1]....
Despite significant advancements in oncology, cancer remains a leading cause of death among adults aged 30 to 70 years. The Global Cancer Statistics indicate that there were 20 million new cancer cases and approximately 10 million cancer-related deaths worldwide in 2022 [1]. Specifically, there...
Gynecological cancer poses a significant global public health concern, with ovarian cancer (OC) as one of the most prevalent malignancies affecting women globally. Due to the insidious onset and lack of typical symptoms of OC, most patients were diagnosed in the advanced stages [1], and mortality ranks...